 Antony Waste Handling Cell Ltd Q2 FY2026 consolidated net profit down QoQ to Rs. 13.65 crores
Antony Waste Handling Cell Ltd Q2 FY2026 consolidated net profit down QoQ to Rs. 13.65 crores Eiko Lifesciences Ltd Q2FY26 consolidated PAT increases to Rs. 1.07 crore
Eiko Lifesciences Ltd Q2FY26 consolidated PAT increases to Rs. 1.07 crore LG Balakrishnan and Bros Ltd Q2 FY2026 consolidated net profit soars to Rs. 93.62 crores
LG Balakrishnan and Bros Ltd Q2 FY2026 consolidated net profit soars to Rs. 93.62 crores Mahindra Holidays and Resorts India Ltd posts higher consolidated PAT of Rs. 17.85 crores in Q2FY26
Mahindra Holidays and Resorts India Ltd posts higher consolidated PAT of Rs. 17.85 crores in Q2FY26 Balkrishna Industries Ltd consolidated Q2FY26 PAT falls to Rs. 273.19 crores
Balkrishna Industries Ltd consolidated Q2FY26 PAT falls to Rs. 273.19 crores 
              Bombay Stock Exchange has announced that effective from Friday, July 11, 2008; the equity shares of Lotus Eye Care Hospital Limited (Scrip Code: 532998) shall be listed and admitted to dealings on the Exchange in the list of ‘B’ Group of Securities.
The equity shares of Lotus Eye Care Hospital Limited (Symbol: LOTUSEYE) shall be listed and admitted to dealings on the National Stock Exchange w.e.f. July 11, 2008. Trading shall be in the Normal Market segment – Compulsory Demat (Rolling Settlement) for all investors.
The ISIN Code of the company is INE947I01017.
The company issued shares in the recently concluded IPO at a price of Rs. 38/- per share (Face Value of Rs.10/- and premium of Rs. 28/-)
S.K.D.C Consultants Limited is the Registrar to the issue.